SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-003962
Filing Date
2020-05-22
Accepted
2020-05-22 16:58:00
Documents
79
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_052120p.htm 10-Q 595139
2 EXHIBIT 10.3 exh_103.htm EX-10.3 36665
3 EXHIBIT 10.4 exh_104.htm EX-10.4 140087
4 EXHIBIT 31.1 exh_311.htm EX-31.1 9652
5 EXHIBIT 31.2 exh_312.htm EX-31.2 9588
6 EXHIBIT 32.1 exh_321.htm EX-32.1 4146
  Complete submission text file 0001171843-20-003962.txt   4984700

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE anik-20200331.xml EX-101.INS 876756
8 XBRL SCHEMA FILE anik-20200331.xsd EX-101.SCH 62157
9 XBRL CALCULATION FILE anik-20200331_cal.xml EX-101.CAL 38972
10 XBRL DEFINITION FILE anik-20200331_def.xml EX-101.DEF 432824
11 XBRL LABEL FILE anik-20200331_lab.xml EX-101.LAB 380518
12 XBRL PRESENTATION FILE anik-20200331_pre.xml EX-101.PRE 461608
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 20906728
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences